Search Videos and More


Dana-Farber Research Publication 1.1.2022 News

Dana-Farber Research Publication 1.1.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 01.15.2023 News

Dana-Farber Research Publication 01.15.2023

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 12.15.2021 News

Dana-Farber Research Publication 12.15.2021

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 12.1.2021 News

Dana-Farber Research Publication 12.1.2021

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Blood Cancer: Higher rates of precursor in high-risk individuals Video

Blood Cancer: Higher rates of precursor in high-risk individuals

Dr. Irene Ghobrial and Dr. Habib El-Khoury shared the first results from the Promise study, which screens individuals at high risk for multiple myeloma.
Implantable Device Helps Predict Drug Therapy Efficacy News

Implantable Device Helps Predict Drug Therapy Efficacy

Dana-Farber investigators recently launched a trial of a miniature device that can be implanted into ovarian tumors to deliver microdoses of different drugs, with the goal of rapidly measuring their effectiveness in killing cancer cells.
Dana-Farber Cancer Institute Faculty Among World’s Most Highly Cited Researchers News

Dana-Farber Cancer Institute Faculty Among World’s Most Highly Cited Researchers

Dana-Farber Cancer Institute is proud to announce that 35 of its researchers have been named to the Highly Cited Researchers list of 2021 released today by the Institute for Scientific Information at Clarivate.
Papers Recount How Research Labs Learned to Work in Four-Part Harmony News

Papers Recount How Research Labs Learned to Work in Four-Part Harmony

A quartet of recent papers in the journal Clinical Cancer Research put the behind-the-scenes efforts involved in a major Moonshot project squarely on the record. The papers provide an inside look at some of the essential start-up activities of the Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC), a network of laboratories and a bioinformatics center established to perform the analytic work involved in developing new immunotherapies for cancer.
Immunotherapy May Yield Longer Treatment-Free Survival than Targeted Therapy in Advanced Renal Cell Carcinoma Patients News

Immunotherapy May Yield Longer Treatment-Free Survival than Targeted Therapy in Advanced Renal Cell Carcinoma Patients

Analysis uses novel endpoint of treatment-free survival (TFS) to ‘better balance the efficacy and toxicity to patients’